Thursday, May 31, 2012

These Stocks are Turning the Corner. Time to Sell?

This article is part of our Rising Star Portfolios series.

Let's say you've found a company that, after years of negative free cash flow, has finally turned positive. Is it time to buy?

Perhaps. But it may also be a huge mistake.

How's that?
It all depends on why the business is flipping from negative to positive free cash flow, and whether the market properly understands the situation.

Sometimes companies with negative free cash flow are great buys. My "Next Home Depot" screen is designed to find such businesses -- ones that exhibit the same traits as Home Depot in the mid '80s before it exploded for 1,500% gains over the next 15 years.

As I explain in this article, the market understood that Big Orange was exhibiting negative free cash flow only because it was reinvesting its free cash heavily into its high-growth business. By 2001, that high growth was done, Home Depot's capital expenditures subsided, and the business turned free-cash-flow positive. Not coincidentally, the stock price ceased its upward surge, and has been relatively flat since then.

If a company you own is transitioning to this stage in this same manner, you may want to consider that its high-return days are behind it. I recently constructed a screen to see if I can identify such businesses.

For this screen, I looked for the following:

  • Two years of positive free cash flow, after at least two years of negative FCF
  • Two years of capital expenditure growth slowing to less than 20% annually, after two years of 20% or greater growth
  • A similar slowdown in revenue growth

I isolated only the two years prior to the first FCF-positive year because even Home Depot snuck a positive year into its 15-year run. I just didn't want an occasional anomaly in any of these metrics to eliminate a company that otherwise fits what we're looking for.

Five to chew on
Only five companies passed this screen, and I can't really say any of them are reminiscent of the Home Depot situation. For instance, O'Reilly Automotive (Nasdaq: ORLY  ) had plenty of FCF-positive years prior to the two negative ones caught by my screen. NetSuite (NYSE: N  ) had some up years and some down years for capex growth. Air Methods (Nasdaq: AIRM  ) and Hallador Energy Company (Nasdaq: HNRG  ) were all over the place in each of these metrics.

MetroPCS Communications (NYSE: PCS  ) is perhaps the best fit. Prior to 2009, it had only one year of positive FCF. Its capex growth has stalled somewhat, and revenue growth has decelerated over the past couple of years. However, one of management's strategies is to continue to expand "in and around" its existing markets, as well as in new areas if possible. So it's really hard to say if its big growth days are truly behind it. And, unlike Home Depot, MetroPCS' stock didn't exactly experience a huge run-up in the years before it turned FCF positive.

MetroPCS Communications Stock Chart by YCharts

Not good enough
I had thoughts of this becoming an official screen for my Rising Star portfolio, the perfect complement to my Next Home Depot screen -- but I don't think it's ready for prime time. I don't feel I captured companies that are in the same position Home Depot was in the early 2000s. I'll continue my research and perhaps refine things a bit, and we'll see where the future takes us.

I will officially track this screen's results, however, by making a thumbs-down CAPScall on each of the monthly passing companies. You can follow along by making this CAPS page a favorite.

Are you interested in The Motley Fool's Top Stock for 2012? Just click here to claim your copy of this free special report.

IDEXX Laboratories Catches Analysts Sleeping Again

IDEXX Laboratories (Nasdaq: IDXX  ) reported earnings on Jan. 27. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), IDEXX Laboratories beat slightly on revenue and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue increased, and GAAP earnings per share improved.

Gross margins increased, operating margins increased, and net margins shrank.

Revenue details
IDEXX Laboratories booked revenue of $307.2 million. The nine analysts polled by S&P Capital IQ expected net sales of $303.9 million. Sales were 8.3% higher than the prior-year quarter's $283.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $0.67. The 11 earnings estimates compiled by S&P Capital IQ predicted $0.63 per share on the same basis. GAAP EPS of $0.66 for Q4 were 9.7% higher than the prior-year quarter's $0.61 per share.

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 51.7%, 70 basis points better than the prior-year quarter. Operating margin was 18.0%, 10 basis points better than the prior-year quarter. Net margin was 12.4%, 40 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $314.5 million. On the bottom line, the average EPS estimate is $0.70.

Next year's average estimate for revenue is $1.30 billion. The average EPS estimate is $3.08.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 216 members out of 228 rating the stock outperform, and 12 members rating it underperform. Among 69 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 67 give IDEXX Laboratories a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on IDEXX Laboratories is outperform, with an average price target of $82.14.

The healthcare investing landscape is littered with also-rans and a few major winners. Is IDEXX Laboratories the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.

  • Add IDEXX Laboratories to My Watchlist.

4-Star Stocks Poised to Pop: Suncor Energy

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, Canadian oil and gas giant Suncor Energy (NYSE: SU  ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Suncor's business and see what CAPS investors are saying about the stock right now.

Suncor facts

Headquarters (Founded) Calgary, Canada (1953)
Market Cap $54.2 billion
Industry Integrated oil and gas
Trailing-12-Month Revenue $40.2 billion
Management CEO Richard George (since 1991)
COO Steven Williams (since 2007)
Return on Equity (Average, Past 3 Years) 6.3%
Cash/Debt $3.3 billion / $10.9 billion
Dividend Yield 1.3%
Competitors Husky Energy
Imperial Oil
Shell Canada

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 1,673 members who have rated Suncor believe the stock will outperform the S&P 500 going forward. �

Earlier this month, one of those bulls, All-Star jrich0591, highlighted several of Suncor's positives:

Who knows what 2012 will bring, however, [Suncor] is the largest and best positioned integrated oil and gas company in Canada. One of the major oilsands players. Strong, experienced management team, with the current CFO to take over the top job when the affable Ron George retires in May/June. "Oily" in nature a long-term diversified play with prospects for capital appreciation and dividend growth.

If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its four-star rating, Suncor may not be your top choice.

We've found another energy play we are incredibly excited about -- excited enough to dub it "The Only Energy Stock You'll Ever Need." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.

Timken Beats Estimates Yet Again

Timken (NYSE: TKR  ) reported earnings on Jan. 26. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Timken met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded significantly, and GAAP earnings per share grew significantly.

Margins expanded across the board.

Revenue details
Timken booked revenue of $1.26 billion. The six analysts polled by S&P Capital IQ expected net sales of $1.27 billion. Sales were 18% higher than the prior-year quarter's $1.07 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $1.15. The seven earnings estimates compiled by S&P Capital IQ anticipated $1.07 per share on the same basis. GAAP EPS of $1.12 for Q4 were 22% higher than the prior-year quarter's $0.91 per share.

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 27.1%, 220 basis points better than the prior-year quarter. Operating margin was 13.9%, 290 basis points better than the prior-year quarter. Net margin was 8.6%, 20 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $1.38 billion. On the bottom line, the average EPS estimate is $1.29.

Next year's average estimate for revenue is $5.67 billion. The average EPS estimate is $5.23.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 190 members out of 204 rating the stock outperform, and 14 members rating it underperform. Among 79 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 77 give Timken a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Timken is buy, with an average price target of $58.89.

  • Add Timken to My Watchlist.

Learn about the Research and Benefits of the Sony Ericsson X8

Sony has been at the forefront of designing highly rated devices and Sony Ericsson X8 is among the products of this continued innovation. It is a 3G smart phone, which is of middle range powered by the android operating system. The device market base is wide and the United States is one of the popular markets. Initially shipping done to the phones operated on Android 1.6 but from early 2011, they upgraded it to the newer version 2.1. The small nature of the gadget makes it a preference for many people.

It has a 76mm capacitive touch screen, which is the equivalent of three inches. The resolution of the camera at the back is 3.2 mega pixels and this camera can be accessed either through the backside camera button or touch screen menu. One exciting camera feature is that it allows geotagging of photos.

The device processor is a Qualcomm that has a speed of 600 megahertz. It is also with an accelerometer that is three-axis. It is used for auto-rotation The GPS feature of this phone is in-built. It also has a digital compass and there is provision of a lug for strap attachment. The beautiful thing is that the surface of the device is resistant to scratches.

The phone has custom software, but also creates room for the installation of others. It supports themes, custom applications and design elements. The home screen corners boast is home to four shortcuts, which can be modified. Time-scape, one of popular applications designed by Sony is also available. It is a tool for networking on social sites.

Common applications to be found on the phone include Wise-Pilot navigation, Google maps, Track-ID and Play-Now Arena. The device is compatible with many common programs and the upgrading done in early 2001 has allowed many more to be supported.

One of the most impressive aspects of phone is the design. At the front, there are three buttons; Back, Home and Menu. The right side boasts of two buttons namely, volume and camera button. The top of the device has a headphone jack, USB port and power on and screen lock button

The mentioned features are not the only present ones in Sony Ericsson X8. It offers support for an external memory card, an adobe flash player application, Wi-Fi, a radio and a music player among others. They are not limited to just these as there are a host of many others.

Learn about the advantages and benefits of the Sony Ericsson X8 Cell phone right now! Get all the information you need.

Incoming search terms for the article:
  • sony ericsson x8 benefits

Law Associations, Industry Groups Support Older Americans Act of 2011

The National Academy of Elder Law Attorneys, a professional association of attorneys dedicated to improving the quality of legal services provided to the elderly and people with special needs, announced on Monday their support for Sen. Bernie Sanders’, I-Vt., bill to reauthorize the Older Americans Act.

The Older Americans Act was initially passed in 1965 to provide support for the elderly through community planning and social services. The law established the administration on Aging. In 2006, it was reauthorized and set to expire in 2011.

On Jan. 26, Sanders introduced S. 2037, the Older Americans Act Amendments of 2012. One of the major initiatives proposed in the bill is to revise the Experimental Price Index for the Elderly to better reflect future cost of living adjustments that impact people 62 or older.

Additionally, the bill would clarify the definition of “economic security” when used to determine income needs for housing, health care, transportation, food, long-term care, and other basic needs. The bill also authorizes improvements to the Meals on Wheels program and creates a pilot program and community planning grant program for senior centers.

“NAELA has been a long-time supporter of the OAA. It’s a win for everyone,” NAELA President Edwin Boyer said in a statement. “Programs supported by the OAA help seniors live independently in their homes, while preventing taxpayers from having to pay for more expensive nursing homes, hospitals, and other health care services.”

Sanders is the chairman of the Subcommittee on Primary Health and Aging in the Senate Health, Education, Labor, and Pensions Committee. On Dec. 15, several industry groups wrote to Sanders in support of the Act, including the American Bar Association, the Alliance for Retired Americans and the National Committee to Preserve Social Security and Medicare.

Max Richtman, president and CEO of the National Committee to Preserve Social Security and Medicare, wrote that “there is simply not enough money allocated for OAA programs to meet the needs of our growing elderly population.”

”By helping seniors stay as independent as possible in their homes and communities, these programs also save federal and state government resources from being spent on sometimes unnecessary and often much more expensive care in hospitals and nursing homes,” he wrote.

The Alliance for Retired Americans also stressed the gap between demand and services OAA funding is able to provide. “For years, OAA funding has not kept pace with inflation or the growing population of individuals eligible for services, yet demand by at-risk older adults in need of supportive services has risen and will only continue to rise with the growth in the aging population,” Barbara Easterling, president of the Alliance wrote.

The American Bar Association noted that it adopted a policy in August 2010 that supported the reauthorization of the OAA and put priority on elder justice and the delivery of legal services.

“While the draft bill does not contain all the elements enumerated in our August 2010 policy, it goes a long way toward creating a high-quality, coordinated legal services delivery system in each state that meets the needs of older persons most in need,” according to the ABA’s letter to Sanders.

Do One Percent of Americans Pay 38 Percent of "Taxes"?

A reporter emailed me to ask what I think of this Heritage Foundation blog post from Rob Bluey, headlined �Top 1 Percent Paid 38 Percent of Taxes.� After writing up my response, I figured I would share it with all of you, as well.

The main problem with the post is the headline. The 38 percent statistic regards the federal personal income tax, not �taxes.� The federal income tax is the most progressive major component of the United States tax code, so showing that it is very progressive does not tell you very much about overall tax progressivity.

Bluey also quotes his colleague Curtis Dubay, to this effect: �According to the CBO, the top 1% of income earners pay 30 percent of their income in all federal taxes.� Dubay cites a Congressional Budget Office table which runs through 2007 and includes federal personal income, payroll, and corporate income taxes.

I�d note that high earners have gotten a federal personal income tax cut since 2007, due to the repeal of provisions that stripped high earners of certain deductions. But the main issue here is with corporate income tax. In assigning the incidence of the corporate income tax to individuals, CBO assumes the tax is borne evenly and entirely by owners of capital, which makes its distribution very progressive: the top 1 percent of filers paid 8.8 percent of their income in federal corporate income tax, compared to 0.8 percent for the middle quintile.

Certainly, when thinking about the federal tax burden, it makes sense to count the corporate income tax. The problem with CBO�s approach is that some portion of the corporate income tax�perhaps a majority of it�is borne by wage earners, not capital holders. If you assign some portion of the tax to wage earners, you calculate a lower effective tax rate for the top 1 percent.

A 2004 Heritage paper by Stephen Entin offered this take on the incidence issue, criticizing the CBO methodology.

In years past, the Congressional Budget Office has also suggested that the corporate tax falls about half on owners of capital and about half on the workforce, arguing that the tax depresses capital formation and therefore depresses productivity and wages, shifting at least some of the burden to labor. More recently, the Treasury and the CBO have assumed that the corporate tax is borne by owners of all capital (corporate capital and competing non-corporate capital), and none by workers.

Most economists believe that the burden of the corporate tax is borne to some extent by shareholders, workers, and consumers (who are often the same people in different roles), but they do not agree on the division of the burden. Because of the uncertainty in the profession, the JCT has stopped assigning it to anyone in the official �burden tables.� If the corporate income tax were raised and individual income taxes were cut by equal amounts, the burden tables would show a reduction in the tax on the population with no loss of federal revenue�an ultimate (and quite impossible) free lunch!

Of course, someone pays the corporate income tax even if the JCT cannot point out who it is. In fact, a modern view of the corporate tax in the context of an open, globally integrated economy holds that the burden of the corporate tax falls primarily on labor after all adjustments are taken into account.

I wouldn�t go so far as Entin and say the corporate tax falls �primarily� on labor�I think the jury is out. But it certainly falls partially on labor, and I�d be very surprised if Dubay agrees with CBO that it falls entirely on capital, even though that is the assumption underlying the 30 percent figure.

Finally, I�d note that state and local tax systems tend to be more regressive than the federal tax system, and for good reason�the taxes which it is best for state and local governments to rely on structurally (property tax and especially sales tax) are more regressive than income tax; also, the federal government is better positioned to levy a heavily graduated income tax than the states are. So, the federal tax code should exceed the target level of progressivity for the tax system as a whole, so that state and local taxes can be more regressive.

In summary, I don�t find it particularly alarming or instructive that the top 1 percent of filers pay 38 percent of the federal personal income tax.

Top Stocks To Buy For 2012-1-31-1

Generac Holdings Inc (NYSE:GNRC) achieved its new 52 week high price of $25.42 where it was opened at $25.32 up 0.07 points or +0.28% by closing at $24.96. GNRC transacted shares during the day were over 183,919 shares however it has an average volume of 208,375 shares.

GNRC has a market capitalization $1.69 billion and an enterprise value at $2.18 billion. Trailing twelve months price to sales ratio of the stock was 2.45 while price to book ratio in most recent quarter was 3.35. In profitability ratios, net profit margin in past twelve months appeared at 11.10% whereas operating profit margin for the same period at 15.07%.

The company made a return on asset of 5.09% in past twelve months and return on equity of 16.50% for similar period. In the period of trailing 12 months it generated revenue amounted to $685.71 million gaining $10.21 revenue per share. Its year over year, quarterly growth of revenue was 49.00% holding 62.50% quarterly earnings growth.

According to preceding quarter balance sheet results, the company had $138.72 million cash in hand making cash per share at 2.05. The total of $632.50 million debt was there putting a total debt to equity ratio 126.03. Moreover its current ratio according to same quarter results was 3.64 and book value per share was 7.42.

Looking at the trading information, the stock price history displayed that its S&P500 52 Week Change illustrated 3.38% where the stock current price exhibited up beat from its 50 day moving average price of $21.07 and remained below from its 200 Day Moving Average price of $19.40.

GNRC holds 67.60 million outstanding shares with 25.40 million floating shares where insider possessed 62.14% and institutions kept 40.50%.

Investors Cheer Return of Quantitative Easing by Fed

The headline on comments by Federal Reserve chief Ben Bernanke at his Jackson Hole retreat in August focused on his comments that the economy is going to be just fine, now, don’t you worry. But his body language and other comments suggested that he would “do what it takes” to keep deflation at bay by using an asset-purchasing process that economists call “quantitative easing,” or QE for short.

We facetiously call this “firing up the printing press,” but more seriously it is about using the Federal Reserve’s limitless balance sheet to buy securities such as Treasuries. This process essentially turns pieces of paper issued by the government (the T bonds) into cash that can flow into the nation’s bloodstream and hopefully then used for productive purposes. Another term for this that you might have heard is “monetizing debt.”

In the future, investors believe that the Fed could also use its balance sheet to support the stock market by buying equities — and conspiracy theorists believe the Fed is already actively engaged in this process by buying S&P 500 futures at key junctures to support its mission of helping the financial and monetary system maintain stability.

I don’t want to get into a big argument on whether this is right or wrong — I just want to tell you that the market loves free money and adores talk about the potential for more QE.

Here are the facts, courtesy of a report this week from the analysts at ISI Group in New York:

After the Bank of Japan implemented QE in 2001, the Nikkei went from 8,000 to 18,000. The BOJ then almost completely withdrew QE in 2006 and the Nikkei went all the way back to 8,000.

After the Fed implemented QE in 2009, the S&P 500 went from 700 to 1,200. Since the Fed has stopped expanding QE, the S&P 500 has declined 12%.

Now listen. When the Fed announced QE last year, few people believed it would significantly lift the stock market. Few today still believe that another round of QE would significantly lift the market. However those that do believe it were trading Friday, and they voted in favor. There’s a new theory afoot which suggests that a key channel by which QE impacts GDP is through stock prices.

Personally I think that the Fed will decide to intervene with QE again to help get employment back on track because there is no stomach in Congress for more fiscal stimulus. Jobless claims are breaking out higher again, which is miserable for households and painful for politicians. With Congress forced to the sidelines by the deficit, policy makers will come to think that QE should shoulder the whole load. I’ve seen estimates it could amount to as much as $1 trillion this time — yes, that’s with a T — and do not doubt for a minute that it could happen.

So the summary is: Although the economy and corporate profits are weakening, the government still has bullets it can shoot to defend confidence in the markets. And it will. So while the market can still suffer an accident in the fall — and the coming week could start off rough — I don’t anticipate anything like the massive sell-off we saw in 2008.

Some wags call this effort to try quantitative easing again ”QE 2,” like the grand old British ocean liner formally called the�RMS Queen Elizabeth 2. Let’s hope our QE2 does not suffer the same fate as that namesake, as the ship formerly owned by Cunard is currently mothballed in Dubai.

GDP Not So Bad

You know by now that second-quarter GDP was revised lower on Friday to a 1.6% annual rate, down from the 2.4% original estimate. Consensus expected +1.3%, so this was considered good news. Either way, the data showed what we already knew: the recovery is losing steam.

However there is one other way to look at the number that is not so grim. Most of the revision was due to some math on trade deficits that don’t really give the best picture of the U.S. economy. The biggest part of the revise came because we imported more than previously thought, and exported less. Which is not so great but that’s been going on a long time.

When you exclude net imports and inventory from the GDP number you get a stat called “real final sales to domestic purchasers” — and that was revised up to 4.4%, from 4.1%. It was the highest number since the first quarter of 2006, and suggests that final domestic demand has picked up. Ned Davis Research analysts say this shows “final domestic demand has picked up, and if sustained will prevent a return of recession.”

Another positive in the report: On a year-over-year basis, before-tax profits were up 39.2% in the second quarter, near their fastest pace since 1983, according to NDR analysts. Domestic non-financial companies’ profits were up 47%, the most since Q4 2002, while financial profits fell. NDR says the data shows that both overall and non-bank profit margins widened to their largest levels since Q4 2006, and are above average for this stage of the business cycle, largely because of a 5.2% reduction in labor and input costs.

So now you can see that if you peer deeper under the hood of these reports, and don’t just accept the quick media once-over, there were some remarkable positives.

What I would like to make sure you understand is that the media narrative about the economy being terrible is not fully accurate. And also we need to recognize that a slowing economy is not the same as a recession. All that the best companies and regions need to be successful is the most modest amount of baseline growth.

There have been many great stock market advances in history when the economy was remarkably weak. One of the most vivid examples was the second and third quarters of 1995, highlighted in the first chart above in the red rectangle.

GDP growth slowed to around 1% then only a year after the 1994 recession, and there were rampant fears of another follow-on recession, or what people now call a “double dip” — just like now. Meanwhile, however, the stock market went straight up, as the Fed was on the case, debt securitization was just getting started and a five-year boom got underway.

The bottom line is that the economy is weak but not a basket case. And in any case, a slowdown in GDP growth does not have to lead directly to a decline in stock prices. The economy and stocks sometimes move in synch, but more often they each march to their own drummer. And if the Fed launches QE II, the market can really take off — at least for awhile.

For more ideas like this, check out Jon Markman’s Traders Advantage or Strategic Advantage advisory services.

Double-Digit Profits No Matter What the Market Does. You are not at the mercy of the markets. You can start adding double-digit winners to your portfolio now if you’re ready to embrace the new rules of investing. Here’s how to make money every day in up markets AND down.

Cheap Stock Alert – SIRI Review

Sirius XM Radio Inc. (NASDAQ: SIRI) stock slipped this morning despite a recent rating upgrade from Morgan Stanley from Non-rated to Overweight. Its price target has been set at $2 price. The research firm also stated that the stock has potential for return of capital in the 2012 and 2013 time period. The company is also likely to attract more institutional investment, which may help in increasing the stock price.

The research report also stated that the company is expected to face increase in its market costs. The note said, �Particularly as SIRI faces competition from internet-based services enabled by wireless device proliferation.�

Sirius is engaged in the business of broadcasting music, news, talk shows and sports in the United States. The company provides its services for a subscription fee. It also streams some of its content over the internet. The company has four in-orbit satellites and 125 terrestrial repeaters. The company has recently submitted a certificate of ownership for the completion of its merger with XM Satellite Radio. The company had been working towards this merger since 2008.

SIRI stock opened at $1.76 and touched the high of $1.80, which is also its 52 weeks high. The stock�s lowest price in today�s session is $1.75. The company stock�s beta is 1.95. The company stock has traded in the range of $0.79 and $1.80 during the past 52 weeks. The company�s market cap is $6.95 billion and its P/E ratio is 75.26.

SIRI had reported its revenue for the quarter ended on Sep. 30, 2010, at $717.549 million. Its gross was stated at $351.865 million while its net income for the quarter was reported at $67.371 million. SIRI had stated its total current assets at $778.615 million whereas its total assets were valued at $7231.785 million. SIRI had total liabilities worth $6962.693 million at the end of the Sep. 30, 2010, quarter.

  • Need fast service and cheap rates from a broker? Click here to see my favorite place to trade SIRI
  • Want more? Check out the message board buzz for SIRI
  • See which newsletters are recommending this stock pick
  • Get breakingnews alerts on this stock:� http://thestockmarketwatch.com/

Buy, Sell or Hold: 100 Billion Reasons To Buy Apple Stock

Apple Stock is a "Buy"When you get down to it, all you need to know is that Apple:

  • Is debt free;
  • Has about $100 billion in cash;
  • Is growing demand at a rate of 100%;
  • And will be putting its cash to work in the future.
Apple is unique among companies in that it could be rated AAA if it wanted to issue debt. Logically, though, why would it? It's built up the largest cash position in history.

In fact, it's the sheer size of the cash hoard that makes this company so interesting. Apple has enough money to change entire industries just by its business demands.

Today, Apple has grown into the largest consumer of chips in the world. Their lineup of tablets, computers, and cell phones has grown to such a degree that the mobile computing trend that Apple launched and dominates is now the driver of chip designs for the future.

This is where I believe Apple will be putting its cash to work. Apple doesn't need to buy back shares or pay a dividend if it has a better use for that cash.

I expect to see Apple purchase chip designers and invest in its capacity to manage its product-line sourcing. I think its next major product will see its early product cycle kept in-house.

Meanwhile, the growth rates at Apple are simply staggering. iPad revenue increased by 100% year-over-year in the fourth quarter alone, while iPhone revenue increased by 133% year-over-year.

You can expect this to continue as Apple cranks out more unique and compelling products in the years ahead.

Action to Take: Buy Apple Inc. (NASDAQ: AAPL) (**)

Apple has the capacity to change the lifestyle of its consumers. While Steve Jobs is no longer around, his impact will be felt for years to come.

In a world of uncertain economic outcomes, Apple rises above the storm as a safe location to park capital. While it currently does not pay a dividend, that could change soon. Even if it doesn't, the rate at which the company is building up its cash hoard allows an investor a comfortable night's sleep. Apple is about as safe a company as you can invest in.

Let's pick up 50% of our Apple shares in the near future, with the rest entered as good-"til-cancelled around the breakout area of the latest earnings report. This should be retested at some point and will give a patient investor a good location to add to their long-term holdings.

(**) Special Note of Disclosure: Jack Barnes has no interest in Apple Inc. (NASDAQ: AAPL).

Market Extra: Procter & Gamble faces growing skepticism

SAN FRANCISCO (MarketWatch) � Procter & Gamble, the world�s largest maker of daily household essentials, faces growing skepticism on Wall Street as it continues to lose ground in most of its core product markets. And this isn�t exactly good for the struggling stock.

On Monday, P&G, maker of billion-dollar brands Pantene shampoo and Tide laundry detergent, was downgraded by two stock-equity analysts who are growing concerned the consumer staples giant can reverse the trend.

Click to Play Fed pushes savers over the edge

MarketWatch.com columnist Chuck Jaffe discusses how the Federal Reserve, by keeping interest rates low for several years, is pushing savers to risky territory. Photo: Reuters.

P&G PG � shares fell almost 2% to $63.18 in afternoon trades.

UBS cut the stock to neutral from outperform, while BMO Capital lowered its rating to market perform from outperform. In addition, they and other analysts slashed their fiscal 2012 profit estimates and stock-target prices.

In its earnings report Friday, P&G dashed investor hopes that it would �improve earnings growth� this year as CEO Bob McDonald had pledged three months ago. Market share losses, a weak euro and price-wary consumers didn�t help. P&G cut its June 2012 fiscal earnings outlook to between $4 and $4.10 a share. Analysts had expected $4.33 a share.

So how did price hikes on Cascade dishwasher detergent and other items affect business in the recent quarter?

P&G said it lost market share on 13 of its 24 brands that make more than $1 billion in sales a year. Demand was weaker in economically-richer markets like North America and Western Europe. Volume rose 1%, not close to the growth rates in fiscal 2011.

Reuters

Meanwhile, gross margin slipped to 49.7% from 51.8% of sales as P&G continued to absorb lofty costs for resins and other commodities.

P&G shares, historically seen as a good stock investment during volatile economic times, haven�t been the leader that one would assume.

Since January 2009, P&G shares � including dividend payments that aren�t reinvested back into the stock � have returned 24% based on current trading prices. The S&P 500 has returned 56% on a comparable basis, according to FactSet Research data.

Over the past year, P&G�s stock is down 1.6% (excluding its annual dividend payment of $2.10 a share) compared with a 10% gain for the S&P Consumer Staples Index.

�P&G is the company that investors look towards to absorb volatility instead of falling victim to it. From where we sit today, it is hard to see how the next one to two years will [be] any different than the last five,� UBS analyst Nik Modi wrote in his report Monday.

On a forward basis, P&G is trading at a price-to-earnings ratio of 15.5 times the consensus profit estimate of analysts. That valuation is a premium to the S&P 500, which is trading at 13.6 times earnings.

/quotes/zigman/238894/quotes/nls/pg PG 62.32, -0.63, -1.00% /quotes/zigman/3870025 SPX 1,313.32, -19.10, -1.43%

Despite the company�s recent setback, Oppenheimer analyst Joseph Altobello still thinks P&G shares are worth owning.

�We believe there is some reason for optimism, and that the worst is behind us, as market shares should improve and commodity pressures wane,� Altobello wrote. He kept his outperform rating on P&G.

If so, P&G shares could climb 12% over the next 12 to 18 months, according to the average target price of analysts surveyed by FactSet.

Stocks to Watch: Stocks to watch Tuesday: Exxon, Mattel

CHICAGO (MarketWatch) � Among the stocks that could see active trade in Tuesday�s session are Exxon Mobil Corp., Mattel Inc. and Pfizer Inc.

Exxon Mobil XOM �is slated to report its fourth-quarter results before the opening bell. The energy behemoth is expected to earn $1.98 a share on revenue of $118.8 billion, according to the average estimate of analysts polled by FactSet Research.

Click to Play U.S. stocks pare steep losses

Stocks pared losses Monday but still finished in the red as investors focused on the standoff between Greece and its private creditors and a surge in Portugal's borrowing costs.

Toymaker Mattel�s MAT �results are also up in the morning, and it�s seen earning $1.01 a share with sales of $2.23 billion for the fourth quarter.

Also, Pfizer PFE �will report its latest financials and should record a profit of 47 cents a share with revenue of $16.61 billion if Wall Street�s best guess is on the mark.

Other companies due to report quarterly numbers include Tyco International Ltd. TYC �, United Parcel Service Inc. UPS �and Archer Daniels Midland Co. ADM �

Shares of RadioShack RSH �came unglued in after-hours action Monday, losing 19% after the electronics retailer said that its fourth-quarter profit would be cut by 75% and come in well below Wall Street hopes.

Wednesday, May 30, 2012

SM: Tax Exemptions for Children

Allowing your ex to have the child's exemption won't preclude you as the custodial parent from being able to claim head of household filing status, which is more beneficial than single filing status.

For example, say there are two kids who will both live primarily with the mother. The father (the noncustodial parent in this case) can be given the exemption for one child while the custodial parent (the mother) claims the other. Or the father can be given both. Or each parent can take both exemptions every other year. Any other arrangement the parents can agree on is OK too.

However, you must also keep the Internal Revenue Service happy. For any year an exemption is given to the noncustodial parent, that person must file a copy of Form 8332 (Release/Revocation of Release of Claim to Exemption for Child by Custodial Parent) with his or her return. The custodial parent must sign the form. The original should be kept with the noncustodial parent's tax records.

If you will be the noncustodial parent, make sure to get Form 8332 autographed by your soon-to-be ex at the final powwow when all the other divorce-related documents are being signed. If you forget, good luck getting your ex to sign off later.

For 2012, the exemption deduction for a child is $3,800.Remember, the exemption is even more important if you are counting on claiming the child tax credit (worth up to $1,000 per qualifying kid), or either of the two education tax credits for your child's college expenses (worth up to $2,500 per student), or the interest deduction for college loans. Even if you are footing all the bills, these tax breaks (among others) are off-limits unless you can also claim the exemption for the child in question. Similarly, using the child to claim head of household filing status, the childcare tax credit, or the earned income tax credit is only allowed if you can claim the exemption for the child.

Exxon reports $9.4 billion profit

NEW YORK (CNNMoney) -- Exxon reported a 2% rise in fourth-quarter earnings Tuesday as higher oil prices offset declining production volumes.

The largest U.S. oil company also defended its focus on natural gas, which is part of its plan to develop unconventional energy sources in the United States.

Prices for natural gas have remained in a deep slump, falling more than 25% in the fourth quarter.

David Rosenthal, the company's vice president of investor relations, blamed mild winter weather and weak economic growth in Europe for cutting into demand.

But Exxon is optimistic about the future prospects for the fuel that's used to heat buildings and generate electricity.

"We remain bullish on the future of natural gas as an energy source," Rosenthal told analysts in a conference call. "Given the steep decline in conventional gas, unconventional gas will pay dominant roll going forward."

Natural gas prices fell 8% Tuesday, while oil prices edged higher.

The biggest winners of Obama's natural gas push

Before the market opened Tuesday, Exxon reported net income of $9.4 billion, or $1.97 a share, in the fourth quarter. That's up from $9.25 billion, or $1.86 a share, in the same period in 2010.

Analysts were expecting earnings of $1.96 a share, according to a survey by Thomson Reuters.

Revenue rose 15% to $121.6 billion, the company said.

For the full year, Exxon earned $8.43 per share, in 2011. Analysts were expecting annual profits of $8.42 per share.

Shares of Exxon (XOM, Fortune 500) were down 2% in midday trading.

The results reflected higher oil prices, which jumped 25% in the quarter. But the industry has struggled to increase production as global oil supplies become more scarce.

Oil-equivalent production fell 9% in the fourth quarter, though it was up 1% for the full year.

Rosenthal said overall production was impacted by entitlement volumes, which reflect payments made to governments and other partners, and other quotas.

The company said earnings from oil exploration and production rose 18% to $8.8 billion in the quarter. But lower volumes and a negative impact from Exxon's production mix reduced earnings by $1.4 billion.

Forget Iran, Iraq is threatening oil prices

Exxon said earnings from its oil and gas refining operations declined during the quarter, citing tighter profit margins. Earnings from the company's chemicals business also declined.

Rival oil company Chevron (CVX, Fortune 500) reported a 3% decline in quarterly profits last week, as its oil and gas production fell to the lowest levels in years. ConocoPhilips (COP, Fortune 500) also reported declining production volumes, even as profits rose in the quarter.

On Saturday, Exxon announced plans to sell its stake in a Japanese refining business to TonenGeneral Sekiyu for $3.9 billion.  

Marcus Grubb: Gold Demand Driven by East/West Divide

By Julian Murdoch

As we covered yesterday, the nature of demand inthe gold market is in flux. Emerging market consumers, not Western buyers, currently drive the bulk of jewelry and physical bullion purchases. Meanwhile, investors in the U.S. have turned to gold ETFs more as trading vehicles than stores of value. Demand has evolved — even from quarter to quarter.

Marcus Grubb is the managing director of investment for the World Gold Council, where he leads both investment research and product innovation, as well as marketing efforts surrounding gold's role as an asset class. Grubb has more than 20 years' experience in global banking, including expertise in stocks, swaps and derivatives.

After the release of the World Gold Council's quarterly Gold Demand Trends survey, Hard Assets Investor spoke with Grubb to get more details on the particulars of some of the report's more surprising conclusions.

Julian Murdoch (Hard Assets Investor): Traditionally, Indian consumers are among the savviest gold consumers. How is Indian demand holding up? And what does that demand pattern tell us about the long-term viability of gold at these price levels?

Marcus Grubb (Managing Director of Investments, World Gold Council): Well, the context for all this is that 2010 was a great year for gold; tonnage reached a 10-year high at 3,812.2 tonnes. And in dollar value, it was an all-time high for the gold market, at $150 billion.

A key element of that was the growth in demand in India in 2010. In total, India reached 745.7 tonnes of jewelry demand, which was up 13 percent [since 1998's peak]. Within that, you had a very strong fourth quarter, continuing the revival of Indian demand last year from the low reached in 2008. And consumer demand, which is a sum of jewelry and investment demand, was up 66 percent relative to 2009. All in all, a very strong picture for the Indian market.

Remember, that's in the face of a very strong gold price in gold markets in 2010, which, despite a small correction, has pretty much continued in 2011.

The other interesting thing, I think, is if you look at recycling. Obviously because India is the largest market, a considerable amount of total recycling comes in from India. But despite a very high gold price, recycling actually fell 1 percent in 2010. Keep in mind, it's 40 percent of supply. Mine production is constrained and growing only slowly, at around 2 percent last year, so the way you can satisfy demand is through recycled gold.

So that shows you the resiliency of the market, and I think it shows also that Indian gold buyers are positive about the future outlook for gold, which is why they're not selling into the strength.

Murdoch: What price level do you think Indian gold buyers will need before they flip that and start selling? What's it going to take to increase the recycling?

Grubb: I think that's much more difficult to determine, the implicit price floor within the Indian market, and generally within jewelry. There's always an element to which if the price goes higher, that may stimulate more recycling. If the price goes lower, you tend to see buyers come back into the market.

So I'd actually flip the logic of your question the other way around, because in the first part of this year we've seen exactly that happening. You saw a largely futures-led sell-off in gold in January, with some redemptions in the ETFs. Mainly long liquidations and rising net shorts on the COMEX drove the gold price down in January between 5.5 to 6 percent. But that was met by strong buying in India and China, and record premiums in the physical market for bars and for jewelry, generally in China, India and some of the other Asian countries.

So you've seen this East/West divide in the early part of 2011. A lot of that has been Indian buying on the dip in the price. You're not seeing a market that's tempted to recycle. You're seeing a market tempted to buy more, because Western investors have pulled back in January, and the prices come down a bit.

Murdoch: One of the other countries mentioned in the report is China. China, which recently reported substantial inflation, increased its demand for small bars and coins 70 percent year-on-year. So who's driving this demand? Are large investors buying gold as an inflation hedge? Or is it smaller investors, individual consumers, augmenting their jewelry buying? Is this the next big retail movement in investing worldwide?

Grubb: It's a fascinating dynamic driving the Chinese market. Last year is a good example. China and India together constituted 51 percent of total jewelry and investment demand in 2010.

Now, India is still the largest market, but what you have developing in China is effectively a catch-up in demand. It's partly driven by the fact that the Chinese market deregulated more recently. It's also driven by the same dynamics in India in terms of economic growth, wealth creation, urbanization and prosperity. And now, increasingly, you have some fear of inflation pressure.

Last year, we put out a report called "Gold in the Year of the Tiger" about Chinese demand. It highlighted that whilst China was now the largest mine producer in the world by country — it's even bigger than South Africa and the United States — it had turned to being a net importer of gold in 2009. In 2010, it imported even more, and for the first part of this year, the figures are very strong.

What you've got is a market that, despite large and growing mine production, is unable to satisfy demand from its own domestic supply. So it's importing gold. That demand is really coming across the board, but you're seeing it very much in the jewelry segment. Looking at the figures for 2010, in China, the change in jewelry [demand] was up 14 percent.

But investment was extremely strong. Total bar and coin investment was up 88 percent. So the story is also on the investment side. And I think that is being driven by retail and affluent investors.

Murdoch: How does Chinese inflation play into this, though?

Grubb: Even with a rising renminbi against the U.S. dollar, China is still sucking in exchange reserves (including the U.S. dollar) at around $190 billion every quarter. First of all, that causes inflation, because it gets into the money supply domestically within China. Secondly, the People's Bank of China currently is seeking to keep in its reserve portfolio about 1.7 percent in physical gold.

Now that becomes a problem when you're bringing in FX reserves at $190 billion every three months. It means unless you want your percent of gold to form your reserve asset portfolio, you have to buy more gold in order to maintain that share of your reserve asset. The issue, though, is that obviously that buying is not transparent to the market. And we can only really guess at that from the strength of the domestic market, from the premiums on the Shanghai Gold Exchange. But if the Chinese Central Bank seeks to keep 1.7 percent of its reserves in physical gold, it's likely to be a buyer when it is pulling FX reserves in at that rate.

Then you have buying among some of the institutions, although that sector is obviously a lot less developed in China. But it's well known that the sovereign wealth fund, the CIC, has a substantial physical gold position through gold ETFs. Also, the World Gold Council in partnership with the ICBC launched a new product last year — a gold accumulation bank account that now has over 1 million account holders and between 10 and 15 tons of gold. That's close to $500 million of gold, achieved in about a year.

So to some degree here, you're seeing physical gold being sought by institutions in China as well.

Murdoch: Speaking of central banks, the Gold Demand Trends Report showed that in 2010, central banks became a net buyer of gold for the first time in 21 years. Is gold on its way back to being a currency standard?

Grubb: Good question. I think the first key thing to point out is, as you've said, the changing paradigm in the central bank sector. It's a major milestone that, after 21 years, central banks have turned into net buyers of gold. They bought around 87 tons in 2010. Our expectation is that this will only continue; that we would expect 2011 to again show net buying.

We can't put a number on it, but when you dissect that, it basically splits into two parts.

Some central banks are very overweight gold for a range of reasons (including historical membership of the gold standard). They have not sold their gold; some still have 40 percent in physical gold of their total reserves. Over the last 20 to 30 years, they have been net sellers. Now that source of supply has ceased.

Then, on the other hand, you're seeing the surface countries accumulating foreign exchange reserves; these include the smaller countries in Asia and Russia up to India and China, in particular. They've been adding to their gold reserves and net-net purchasing more gold. So we think that dynamic is going to continue and, if anything, strengthen in 2011.

We certainly wouldn't advocate or expect a new gold standard. That's not our view. But there may well be an enhanced role for gold in whatever regulatory and financial architecture eventually emerges from the effects of the credit crunch, the recession and now this anemic recovery we're seeing in Western countries. In the central bank sector, there's possibly a role for gold in an SDR [special drawing rights] world, where you add gold into that currency basket. That's obviously wrapped up with China now being the second-largest economy in the world and the potential for renminbi to be an internationally investable currency.

I think there are also moves afoot in the financial markets among some of the banks and exchanges to admit gold as a form of collateral in stock borrowing and lending transactions, and generally in financial transactions. We feel that's a positive step because it's recognizing gold's role as a relatively low volatility store of value in capital transactions and in borrowing and lending transactions.

Finally, I think you're seeing some of the hedge funds — most notably Paulson & Co. — start to look upon gold as a quasi-currency. They have launched share classes for their funds—which are not commodity funds, they're not gold funds — that are denominated in gold as opposed to U.S. dollars, sterling yen or euros. Those share classes are proving very popular. And certainly in 2010, they did very well for their investors.

So I think there are a number of more subtle ways in which gold is becoming reestablished as a monetary asset, and almost as a currency. But we would not advocate a return to the old- fashioned gold standard.

Murdoch: Gold ETFs are clearly the dominant way that big investors decide to express their desire for a safety play in gold. For example, we just saw recently that George Soros increased his position in gold ETFs, albeit slightly. So do you see this as adding volatility to the gold markets?

Grubb: The short answer is no. Just talking physical funds, then our experience as the organization that started that market, is that these instruments have securitized and made accessible an asset class which was previously inaccessible.

In that sense, we feel they haven't contributed, and they don't contribute, to the volatility of the gold price. To me, what bears that out at the moment is the current trailing volatility of gold. Gold volatility is very low right now. It's down to about its normal long-term average, which is around 12-14 percent, which is no more volatile than a major stock index.

So the evidence I think says that ETFs have not caused greater price volatility. For other precious metals, and now in base metals and other commodities, the evidence is clearly different. You know, the ETF flows and the price of those assets is much more volatile. So we feel gold as an asset class has benefited from the ETFs, that they have opened the asset up to a different type of investor base.

Murdoch: Is there a natural point of elasticity for gold demand? Is there a price level at which demand will slacken, and price out the average investor? Or will demand for gold continue forever?

Grubb: History so far shows that what tends to happen is that as the price rises, the amount of grams or ounces you can afford per units of currency declines. So in China and India, consumers have carried on buying; they've just bought less. The price rise has had some impact on the tonnage purchased per unit.

But overall, the growth in demand has been so strong that net-net you've seen a rise in both tonnage and dollar value. That elasticity is very positive for gold.

But I look at it a bit differently. I don't think it's only about the price elasticity of demand. The real key driver is that gold, for a number of reasons, is in demand. And compared with other commodities and other metals, you have an asset that is in much more constrained supply than many of its peers. Mine production is growing only slowly, even in the face of a very strong gold market, and the average time to get a mine to production from finding the gold can be six to 10 years. Basically, the supply response is very inelastic, and that's not the case in a number of other metals.

So I think it's a combination of those two things that's continuing to drive the upward trend in the market, not just the price elasticity of demand side.

Murdoch: Thank you so much for your time.

Grubb: Thank you.

Measuring Risk Asset Performance


Above I'm introducing what I'm calling the Risk Asset Index. It is an initial version of a proprietary measure that assesses the daily performance of risk assets.

The components of the index are emerging market stocks (EEM), U.S. stocks (SPY), oil (USO), Treasury rates ($TNX), and an inverse calculation for U.S. dollar (UUP).

Investors and traders are considered risk-seeking if we have rising EEM, SPY, USO, $TNX and falling UUP. They are considered risk-averse if we have falling EEM, SPY, USO, $TNX and rising UUP.

The index is calculated by adding the daily price changes in the five asset groups. One unique element of the index is that daily price changes are expressed as a function of recent volatility, so that the price changes are directly comparable. This also means that the index is sensitive to shifts in volatility patterns among risk assets.

We can see that the recent bounce in risk assets has only recovered a fraction of the decline since mid-January. On a long-term basis, we're within the broad range between the mid-2008 highs and the early 2009 low; failure to take out resistance in the 100 area would target a move back toward the midpoint of that range--a move which would likely see falling stocks, commodities, and Treasury rates and a rising U.S. dollar.

NAR Overstates House Sales; Case Shiller Shows Price Erosion

As disturbing as the fact is, I am far from being surprised - especially when the source has a vested interest in the data. As reported by Reuters, “The National Association of Realtors, which issues the monthly existing home sales report that is closely watched by economists and financial markets, may have over-counted home sales dating as far back as 2007.”

NAR's home sales count was at odds with calculations by CoreLogic, a California real estate analysis firm, according to the report. CoreLogic says NAR could have overstated home sales by as much as 20 percent. An over-count of home sales may mean that there is a bigger backlog of unsold homes and that it will take longer for the U.S. housing sector to climb out of the deep hole it is already in, dragging on the broader economic recovery.

The NAR said “the data could be revised downward this summer.” How timely and comforting.

In a much smaller scale and restricted to one zip code (77494), I have kept informal tabs on house prices and sales to gauge the health of the housing market. Why this zip code? Because I lived there. And while the national market was sinking, prices were rising in Katy, TX, one of the few hot spots in the country through the housing meltdown due to oil money flowing into this affluent Houston suburb. Since I left in 2009, prices have been under heavy pressure, and houses continue to be discounted, while oil prices have held at healthy levels.

Today, Case-Shiller added yet another sobering bit of data to the harsh reality with prices dropping 2.4%, continuing the discounting process that is far from complete. I don’t mean to look for the glass half-empty, only a healthy dose of reality.



In a conference call, Shiller and Case had differing views going forward. According to MarketWatch, Case "noted that existing home sales have come back after collapsing this summer when the home-buyer tax credit ended." Maybe he had not read the NAR article.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

IBM Boosts Dividend 18%; Expands Buyback Plan By $8 Billion

IBM (IBM) this morning boosted its quarterly dividend to 65 cents a share, from 55 cents, an increase of 18%. The dividend is payable June 10 to holders of record May 10. The stock now has a yield just shy of 2%.

This the 15th year in a row that IBM has boosted its payout; it has paid quarterly dividends since 1916.

The company said its board also authorized an $8 billion increase in its stock repurchase program, boosting the total authorization to $10 billion.

IBM is up 67 cents, or 0.5%, to $131.40.

Tuesday, May 29, 2012

Top Stocks For 2012-2-1-10

SCHAUMBURG, Ill., Aug. 31, 2011 (CRWENewswire) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a specialty pharmaceutical company, today announced U.S. FDA approval of its Orphenadrine Citrate Injection, USP, a skeletal muscle relaxant. Sagent’s orphenadrine will be offered in 60 mg per 2 mL single-dose, latex-free vials. According to 2011 IMS data, the U.S. injectable market for orphenadrine approximated $4.3 million. As with all products in Sagent’s portfolio, orphenadrine features the company’s PreventIV MeasuresSM packaging and labeling designed to aid in the reduction of medication errors. Sagent expects to launch orphenadrine in the third quarter of 2011.

“We are pleased to add orphenadrine to our continuously expanding product portfolio,” said Jeffrey M. Yordon, chief executive officer, founder, and chairman of the board of Sagent. “This is another example of our commitment to the market by rapidly introducing a broad portfolio of quality injectable products.”

About Orphenadrine Citrate Injection, USP

Orphenadrine is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.

Detailed information about the indications, warnings, complete side effect profile, and full prescribing information will be available in the package insert. Please visit www.SagentPharma.com for more information.

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, Inc., founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.

Forward-Looking Statement

Statements contained in this press release contain forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give Sagent’s current expectations and projections relating to its financial condition, results of operations, plans, objectives, future performance and business as of the date of this release. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. Sagent’s expectations are not predictions of future performance, and future results may substantially differ from current expectations based upon a variety of factors, risks and uncertainties affecting Sagent’s business, including, among others, the impact of competitive products and pricing and actions by Sagent’s competitors with respect thereto; the timing of product launches; compliance with FDA and other governmental regulations by Sagent and its third party manufacturers; changes in laws and regulations; and such other risks detailed in Sagent’s periodic public filings with the Securities and Exchange Commission, including but not limited to Sagent’s most recent quarterly report on Form 10-Q and Sagent’s IPO prospectus filed on April 21, 2011. Sagent disclaims and does not undertake any obligation to update or revise any forward-looking statement in this press release, except as required by applicable law or regulation.

Contact:

INVESTOR CONTACT:
Ronald Pauli, Sagent
(847) 908-1604
MEDIA CONTACT:
Geoff Curtis, WCG
(312) 646-6298

Source: Sagent Pharmaceuticals, Inc.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

California Storage Portfolio Standards May Be a Great Kickoff

The California Energy Storage Alliance just issued a press release that describes new legislation to require utilities to incorporate energy storage in their distribution networks. The rules will mandate storage equal to 2.25% of daytime peak power by 2014 and 5% of daytime peak power by 2020. The press release is available here.

A quick check of the California ISO website forecasts a peak load of approximately 29,000 MW for tomorrow. If one assumes an average peak demand of 30,000 MW, a 2.25% storage, penetration would require an annual storage build of 135 MW per year in each of the next five years.

Using the average values reported in the Energy Storage for the Electricity Grid: Benefits and Potential Market Assessment report that I introduced last week, the incremental revenue to storage manufacturers from the sale of grid-scale storage systems in California would be worth roughly $200 million per year.

If the legislation is passed by the legislature and signed into law, the new storage portfolio standards will be great kick-off for the storage sector.

Disclosure: none

FOREX-Euro on defensive as Greece worries persist – Reuters

Geo Television NetworkFOREX-Euro on defensive as Greece worries persist
Reuters
TOKYO, June 27 (Reuters) – The euro struggled near a record low against the Swiss franc on Monday and fell versus the dollar, staying under pressure ahead of this week's decision by the Greek parliament on whether to back …
WORLD FOREX: Dollar Broadly Higher In Early Asian Trading, Euro Hit By Debt …Wall Street Journal
Forex Asia Review � Euro declines for fourth dayTrading Point
Morning Forex Review – Dollar Higher are Global WorriesMarkets
FXstreet.com -IBTimes Hong Kong
all 46 news articles »

{forex} – Google News

Rallying On Decent News, Flat On Bad: Pending Bull Market?

The market had a great day yesterday on the back of strong data out of Europe, China, and some in America. The ISM Index here at home improved MoM, but it did miss expectations as it moved to 54.1. ADP Employment was also released but came in under expectations at 170K. Construction spending was better than expected at 1.5%. Overall, the data was decently positive. Europe and China showed some good manufacturing data, and there was good news out of Greece that they were nearing a debt-swap deal. The market liked this good news and powered higher.

Moving into today, we are getting into a situation now where we are rallying on decent news and flat on bad news. That is a great sign of a bull market. When will it stop? Good question.

Two stocks on our radar are Weight Watchers (WTW) and Monster Beverage (MNST). We like WTW right now as a company that should continue to stay solid into earnings on Feb. 14th and has upside from those earnings as the company is expecting large growth. The options market is pricing in a lot of volatility, and you can still get around 10% in premium selling options as low as 65/62.50 bull put spread, which is over 13% below current price. Additionally, we are watching MNST. The stock has weakened as of late. Earnings are coming in late February, and on any further drops, we would be a buyer. MNST is a strong stock that should be bought on weakness as funds want to own it. It should run up into earnings.

Today we will get some more information about employment with jobless claims and Challenger Job Cuts. Both reports will be more scrutinized moving into non-farm payrolls on Friday. Earnings are also going to be crucial from Chiptole (CMG), Dow Chemical (DOW), Green Mountain Coffee Roasters (GMCR), Kellogg (K), Las Vegas Sands (LVS), Qualcomm (QCOM), and more.

We had a good day yesterday as we got a 2% gain in Ultrashort ProShares DJ-UBS Crude Oil (SCO) that we entered intraday. We got out of a long Cummins (CMI) position we had for a 1% gain. We hit our 0.05 target on sold Blackstone (BX) $14 puts for 26% gain. We also got gains in our Extended Value Portfolio (long-term) in Microsoft (MSFT) as it hit 30.00 for 9.7% gain as well as Vanguard Emerging Markets ETF (VWO) for 10% gain as it hit 43.00.

We have the following positions. In our Short-Term Equity Portfolio we are long Polo Ralph Lauren (RL) and SCO. In our Options Portfolio, we are long Apple (AAPL), Priceline (PCLN), Dollar Tree (DLTR). We are short Deckers Outdoor (DECK) and SPDR S&P500 ETF (SPY). In our Earnings Portfolio, we are long VF Corp. (VFC), CarMax (KMX), Avis Budget (CAR), Vertex Pharma (VRTX), EOG Resources (EOG) and Ashland (ASH). We are short AOL (AOL). We have an iron condor in Amazon (AMZN) as well.

Chart courtesy of finviz.com.

Disclosure: I am long SCO.

7 Fossil Fuel Stocks Stuck In The Mud

People say money makes the world go round. But, those in the know realize this isn’t true. What makes the world go round is the same thing that allows you to sleep comfortably at night. It is the same thing that powers your car on the way to work. It is also the same thing that can arguably cause more harm to the environment than it can benefit the people who use it. The fuel that makes the world go round is, in fact, fuel itself.

Unfortunately, as fruitful of a resource oil, gas and other consumable fuels are to the people of this wide world, there are companies that are struggling to create positive returns from it. I watch more than 5,000 publicly traded companies with my Portfolio Grader tool, ranking companies by a number of fundamental and quantitative measures. This week, I’ll tell you about seven oil, gas and consumable fuels stocks that have been having a tough time over the past 12 months.

Here they are, in alphabetical order. Each one of these stocks gets a �D� or �F� according to my research.

Arch Coal (NYSE:ACI) is a coal producing company. ACI has posted a significant loss of 58% in the last year. ACI stock a �D� for operating margin growth, an �F� for earnings growth, an �F� for earnings momentum, an �F� for its ability to exceed the consensus earnings estimates on Wall Street and an �F� for the magnitude in which earnings projections have increased over the past month in my Portfolio Grader tool. For more information, view my complete analysis of ACI stock.

Encana (NYSE:ECA) is a producer of natural gas that has watched its stock value dip 40% in the last 12 months. ECA stock gets a �D� for sales growth, an �F� for operating margin growth, an �F� for earnings growth, an �F� for cash flow and a �D� for return on equity in my Portfolio Grader tool. For more information, view my complete analysis of ECA stock.

Hess (NYSE:HES) is an explorer and producer, as well as a marketer and refiner for integrated oil products. In the past year, HES stock is down 33%. HES stock gets a �D� for operating margin growth, an �F� for earnings growth, an �F� for earnings momentum, an �F� for its ability to exceed the consensus earnings estimates on Wall Street, a �D� for the magnitude in which earnings projections have increased over the past month and an �F� for cash flow in my Portfolio Grader tool.For more information, view my complete analysis of HES stock.

Petrobras Petroleo Brasileiro (NYSE:PBR) is a Brazilian integrated oil and gas company and has posted a loss of 13% in the last year. PBR stock gets a �D� for earnings growth, a �D� for the magnitude in which earnings projections have increased over the past month and a �D� for cash flow in my Portfolio Grader tool. For more information, view my complete analysis of PBR stock.

Southwestern Energy (NYSE:SWN) is involved with the exploration, development and production of oil and natural gas. In the past year, SWN stock has dropped 21%. SWN stock gets a �D� for operating margin growth, a �D� for its ability to exceed the consensus earnings estimates on Wall Street and a �D� for cash flow in my Portfolio Grader tool. For more information, view my complete analysis of SWN stock.

Talisman Energy (NYSE:TLM) is a global, diversified, upstream oil and gas company. TLM is down 48% in the past 12 months. TLM stock gets a �D� for operating margin growth, an �F� for its ability to exceed the consensus earnings estimates on Wall Street and an �F� for cash flow in my Portfolio Grader tool. For more information, view my complete analysis of TLM stock.

Total S.A. (NYSE:TOT) is an oil and gas company based in France. TOT rounds out the list with a loss of 10% in the last 52 weeks. TOT stock gets an �F� for sales growth, a �D� for earnings growth, a �D� for its ability to exceed the consensus earnings estimates on Wall Street, a �D� for the magnitude in which earnings projections have increased over the past month and a �D� for cash flow in my Portfolio Grader tool. For more information, view my complete analysis of TOT stock.

Get more analysis of these picks and other publicly traded stocks with Louis Navellier�s Portfolio Grader tool, a 100% free stock rating tool that measures both quantitative buying pressure and eight fundamental factors.

Auction Houses Clean Up as Art Gains Appeal

Want to know where investors are placing some of their biggest bets? Look on their walls.

Art prices swelled last year, lifting sales at Christie's International PLC to $5.7 billion last year, up 14% from the year before. The London-based auction house said on Tuesday that the total includes $4.9 billion in auction sales and $808.6 million in art sales it brokered privately, as galleries typically do. The private-sale total doubled from a year ago, it added.

Christie's Priciest Paintings of 2011

View Slideshow

Christie's

Artist: Andy Warhol Title: 'Self Portrait,' 1986 Sold for: $27.5 million

Christie's auction sales matched those of its chief rival, Sotheby's, which said it auctioned off $4.9 billion of art last year, up 14.5% from the year before. Sotheby's, which is publicly held, said it would disclose its private sales later this month.

Steven Murphy, chief executive of the privately held Christie's, said collectors and investors alike see art as a potentially safe haven for their cash at a time when the broader financial outlook remains volatile: "Everyone is doubling down on art," he said. "That's why our market is so strong now."

Overall, art values rose 10.2% last year, according to art-market analyst Michael Moses, whose New York firm Beautiful Asset Advisors runs indexes that track shifts in the sale prices of thousands of artworks that have sold at auction more than once over the years.

The Top 10

The priciest lots sold at auction at Christie's in 2011

$43,202,500 Roy Lichtenstein (1923-1997), I Can See the Whole Room!...and There's Nobody in it!, 1961
$38,442,500 Andy Warhol (1928-1987), Self-Portrait, 1963-1964
$35,906,000 George Stubbs, A.R.A. (1724-1806),Gimcrack on Newmarket Heath
$33,682,500 Mark Rothko (1903-1970), Untitled No. 17, 1961
$29,133,148 Pablo Picasso (1881-1973), Femme assise, robe bleue, 1939
$28,666,155 Francis Bacon (1909-1992), Study for a Portrait, 1953
$27,522,500 Andy Warhol (1928-1987), Self-Portrait, 1986
$25,282,500 Francis Bacon (1909-1992) ,Three Studies for Self-Portrait, 1974
$22,482,500 Claude Monet (1840-1926), Les Peupliers, 1891
$22,482,500 Maurice de Vlaminck (1876-1958),Paysage de banlieue, 1905

Source: Christie's

The pace of art buying varies around the world, though. Collectors in the U.S. shopped cautiously last year, with Christie's sales in America dropping 3%, to $1.9 billion, from the year before. Its sales also were down 64% in Dubai, to $18.6 million. On the other hand, European collectors—particularly those from Italy and Switzerland—stepped up their bidding. Christie's sales in Europe totaled $2.2 billion, up 29% from 2010.

Christie's greatest triumph came from Roy Lichtenstein, whose 1961 comicbook-style painting of a young man staring through a peephole, "I Can See the Whole Room…and There's Nobody in It!," sold for $43.2 million in November, setting a new record for the Pop artist.

Sotheby's fared even better with Clyfford Still's jagged abstract, "1949-A-No. 1," which sold for $61.7 million in November.

Both houses seized on collectors' wider interest in contemporary art, a category that includes works created since 1949. The style is particularly popular with newly wealthy, younger buyers who want art made by their generational peers.

But price levels for these contemporary artists tend to shift unpredictably, which also attracts speculators seeking to profit from changing art values. Christie's sold $1.2 billion of contemporary art last year, up 27% from a year earlier.

Asia flexed its expanded purchasing power in the marketplace last year thanks to an influx of new collectors from mainland China who ratcheted up prices for hometown favorites like scroll painter Qi Baishi as well as global mainstays like Pablo Picasso. Christie's said 13% of the bids it fielded last year came from collectors in greater China.

For the first time, Asian art also became Christie's second-biggest seller of the year after contemporary art, with sales of $890.1 million. Christie's priciest work of Asian art last year was Cui Ruzhuo's $15.9 million scroll painting, "Lotus," from 2011.

Sales of Impressionist and modern art proved a disappointment, though. Christie's sales of this high-profile category dropped 26%, to $883.3 million, last year. Its top price in the segment was $22.4 million for Claude Monet's landscape "Poplars," but the house failed to find a buyer for another major work, Edgar Degas's ballerina sculpture, "Little Dancer, Age 14." The Degas was priced to sell in November for at least $25 million, but bidding stalled at $18.5 million.

Dealers said this reshuffling of Christie's marquee categories reflects Asia's rising clout but also underscores the dwindling supply of Impressionist and modern masterpieces still circulating in the marketplace. The majority are already tucked away in museums, ostensibly for good. (Auctioneers are working harder to promote easier-to-find Surrealist painters like René Magritte, who is known for painting green apples and bowler hats, and Paul Delvaux, known for his lounging nymphs.)

Looking ahead, expect the top houses to bolster their offerings online as well. Christie's said nearly a third of its bidders last year shopped by bidding online, a 2% rise from 2010. Christie's also got $9.5 million from its first online-only sale of lower-priced goods from the estate of actress Elizabeth Taylor in December. Ms. Taylor's pricier jewels and couture clothing were still sold the traditional way, in a series of live auctions that brought in an additional $147 million.

The art market will be tested again next week as Christie's, Sotheby's and smaller auctioneers Bonhams and Phillips de Pury & Co. kick off a two-week round of major auctions of Impressionist, modern and contemporary art in London.

Write to Kelly Crow at kelly.crow@wsj.com

Monday, May 28, 2012

What’s a Better Buy — Energy Stocks or Partnerships of the Same Name?

An investor named Donald recently wrote me asking a very good question about companies that operate both as a conventional corporate entity and a related partnership under the same name.

“What is the difference between Cheniere Energy Inc. (NYSE:LNG) and Cheniere Energy Partners LP (NYSE:CQP)? I do know that CQP is an MLP [master limited partnership] and pays a dividend and LNG is a stock. But which one owns which? Which one is safest? Which one is potentially the biggest gainer?”

This question applies to many energy companies, including Cheniere,� Kinder Morgan Inc. (NYSE:KMI) vs. Kinder Morgan Energy Partners (NYSE:KMP), and a host of others. I’ll steer clear of individual stock analysis and instead try to focus on the differences between an Inc. and an LP under the same name.

In the case of Cheniere, CQP is a partnership with a big dividend, and LNG operates under the model of a profit-seeking stock out for growth. The “parent” in this case is is Cheniere Inc., which owns about a 90% stake in the partnership — and that’s typically the case. Some partnerships are sliced and diced more creatively. For instance, Kinder Morgan Inc. owns 11% of KMP, and a third publicly traded stock, Kinder Morgan Management LLC (NYSE:KMR), owns about 30% more of the KMP partnership.

I know, confusing. You can’t tell the players without a program sometimes. But the good news is that a quick review of company profiles in Yahoo! Finance or Google Finance will offer the relevant details for almost every Inc. vs. LP ownership question.

Now we get to the sticky part… which one is “safest” or the “best” investment. Well, let’s look at Cheniere as a case study. CQP is a �pass through� partnership, meaning it’s simply a toll collector operating a Louisiana facility. It takes a fee from anyone who moves energy through its terminal. That is very low risk, since it�s unlikely business will ever dry up for CQP unless there’s a brutal supply-chain problem or global demand disruption on a large scale. Hence, the big dividend due to a reliable revenue stream.

But it also means there isn�t a lot of upside potential, since CQP stock will never break out� it�s not like it will open a port in Dubai or Australia in 2012, after all.

LNG, on the other hand, has definite breakout potential. Case in point: It�s up 70% in the last year because it can operate as a company seeking big growth in profits and revenue. The downside? It could also drop just as sharply, and it doesn�t pay a penny in dividends. It’s also bleeding cash, if you look at the balance sheet, which proves that its revenue and profits aren’t nearly as reliable.

So, the bottom line is that you’re faced with a strategic choice here: Go for a sleepy income investment, or go for a company that could deliver big share appreciation but also fall off a cliff.

Which one should you chose? Well, It all depends on what kind of investor you are and what kind of portfolio you�re trying to build. In this case, as with so many others in investing, it’s question of how much risk you’re willing to take on in the quest for bigger rewards.

Got a question for InvestorPlace staffers? Drop us a line at editor@investorplace??.com!

Jeff Reeves is the editor of InvestorPlace.com. Write him at editor@investorplace??.com, follow him on Twitter via @JeffReevesIP and become a fan of InvestorPlace on Facebook. Jeff Reeves holds a position in Alcoa, but no other publicly traded stocks.

Daily ETF Roundup: VGK Bolstered By Debt Negotiations, UNG Continues To Sink

Stocks endured yet another bumpy trading session as indexes oscillated between gains and losses for most of the day thanks to mixed economic developments. On the home front, Exxon Mobil posted strong quarterly earnings, although lackluster home prices data overshadowed the energy giant’s profits. The Nasdaq proved to be most resilient, gaining 0.07% on the day, while the Dow Jones Industrial Average slipped lower, shedding 0.16% as the trading session drew to a close. Gold prices whiplashed back-and-forth as investors dealt with conflicting developments; futures contracts for the precious metal soared as high as $1,750 an ounce, only to tumble back to $1,730 an ounce in a matter of hours, and finally settle near the $1,740 level as the closing bell rang.

Sentiment took a pessimistic turn on Wall Street after a string of worse-than-expected data releases [see also How To Invest Like UBS In 2012]. The Case-Shiller home prices index came in at -1.3%, which showed a modest slump from the previous reading of -1.2%. Consumer confidence data was also disappointing; the latest reading came in at 61.1, missing estimates entirely as it fell short of the previous reading at 64.5. Developments overseas were mixed as well after German employment came in better-than-expected, although Canadian GDP dipped to -0.1% on a month-over-month basis.

The Vanguard European ETF (VGK) was one of the best performers, gaining 0.65% on the day, bolstered by encouraging developments in the debt burdened currency bloc. Investors were cheerful to see that Greece is moving closer towards finalizing an austerity plan; Finance Minister Evangelos Venizelos commented, “We are one step � I would say it is a formality� away from finalizing the debt relief agreement”. The debt deal includes a 50% haircut to Greek bondholders along with a longer repayment period and lower interest rates [see Euro Free Europe ETFdb Portfolio].

The United States Natural Gas Fund (UNG) was one of the worst performers, shedding 6.91% on the day, as natural gas prices resumed their volatile descent. Fuel prices plummeted over 9% in the commodities market after a government report signaled that U.S. production hit a record high. Natural gas has been absolutely beat down over the past few months as weak demand, thanks to a mild winter, coupled with piling supplies, has paved the way for record-low prices [see also Energy Bull ETFdb Portfolio].

[For more ETF analysis, make sure to sign up for our free ETF newsletter or try a free seven day trial to ETFdb Pro]

WORLD FOREX: Dollar Broadly Higher In Early Asian Trading, Euro Hit By Debt … – Wall Street Journal

USA TodayWORLD FOREX: Dollar Broadly Higher In Early Asian Trading, Euro Hit By Debt …
Wall Street Journal
–Euro hit by continued concerns over debt issues with key Greek parliamentary votes on austerity measures being closely watched. –Falls in share and commodity prices also hit the risk-sensitive euro, further boosting the dollar. …
FOREX-Euro pummeled, hit by Greek austerity doubtsReuters
FOREX: US Dollar Weakness on Greek Aid Deal a Buying OpportunityDaily FX
Forex US Review -Most majors end the week down, Dollar stays strongTrading Point
�Market Leader� – news and previews making you rich. -NASDAQ -Forex Rate It!
all 3,145 news articles »

{forex} – Google News

Achillion, Idenix could miss hep-C merger bonanza

BOSTON (MarketWatch) -- Investors tantalized by a recent string of lucrative takeover offers for hepatitis C drug-developers shouldn�t assume that an eye-popping bid for Idenix Pharmaceuticals and Achillion Pharmaceuticals is just around the corner, according to biotech analysts.

Both Idenix IDIX �and Achillion ACHN �were put in play earlier this month by news that Bristol-Myers Squibb BMY � intends to buy Inhibitex Inc. � for $2.5 billion in cash.The offer represents a dazzling 163% premium over Inhibitex�s pre-bid closing price.

Click to Play Pfizer's post-Lipitor world

With its exclusive window on cholesterol drug Lipitor long closed, Pfizer is looking to the post-Lipitor world.

Bristol�s bid also comes on the heels of two other lucrative takeovers in the hepatitis C virus, or HCV, arena. In October, Roche RHHBY � announced it was paying a stunning 256% premium, or $230 million, for tiny Anadys Pharmaceuticals. That was followed by Gilead Sciences�s GILD � whopping $11 bid for Pharmasset Inc., which carried an 89% premium.

Rumors have since swirled that other Big Pharma players are likewise eyeing the HCV space. And that speculation has helped push up Idenix shares by a hefty 80% and Achillion shares by 45% since the beginning of the year.

At stake is a market filled with a backlog of under-treated HCV patients that many analysts believe could reach $10 billion a year within the next five years.

But here�s the kicker -- because the new HCV drugs can actually cure the disease, their demand will likely drop over time after the backlog of patients is treated. Despite this, most analysts agree the market should be able to coast along at the $10 billion level for at least ten years. And because time is of the essence, companies with HCV drug candidates in mid-to-late stage development have been considered the hottest takeover targets.

/quotes/zigman/100395/quotes/nls/achn ACHN 6.50, 0.00, 0.00% Achillion shares

Of the two companies, Idenix�s stock has seen the most action largely because its lead drug candidate hails from a highly-touted class of drugs called nucleotides, or �nukes.� Both Inhibitex�s and Pharmasset�s lead drug candidates are nukes, which is what made them particularly attractive acquisitions.

�I don�t think Idenix�s stock�s bid too high,� said Wedbush Securities analyst Duane Nash, who tracks Idenix. �But the caveat is that acquisitions generally take longer than most people anticipate.�

While Wedbush currently has Idenix�s fair market value listed at $15 a share, Nash believes that Idenix could fetch a takeout price of between $20 and $25 a share. The stock closed at $13.39 on Tuesday.

William Blair analyst Katherine Xu, meanwhile, said she believes Idenix�s current takeout range is probably between $15 and $20 a share. Xu currently has a price target of $10 on the stock.

Xu added that she could be raising her target into the mid-to-high teens if and when U.S. regulators give the green light to an Idenix�s clinical trial that has been placed on partial hold over safety concerns. The decision is expected within the next few weeks.

�I doubt people will take it out before the hold is removed,� she said.

But analysts also point out that Novartis AG�s NVS � roughly 30% equity stake in Idenix could hinder a takeover bid, especially as the Swiss pharmaceutical giant reportedly has options to some key drug candidates.

Meanwhile, JMP Securities analyst Liisa Bayko thinks that investors have overvalued Idenix�s nuke drug candidate, which she says isn�t as potent as those being developed by Inhibitex and Pharmasset. Because of this, Bayko has a sell rating on the stock.

As for Achillion, the reason its shares haven�t been bid up as high as Idenix�s is largely because its lead drug candidate is a protease inhibitor, a class of drugs that includes Merck & Co.�s MRK � Victrelis and Vertex Pharmaceuticals�s VRTX � Incivek, which were both launched last year. Several other drug developers already have protease inhibitors in their pipelines.

Xu said that while she currently has Achillion�s price target at $15 a share, its takeout range is probably between $15 and $20. The stock closed at $11.09 on Tuesday.

�I think it�s still undervalued at the moment,� she said.

Wells Fargo Securities analyst Brian Abrahams said that even though Achillion�s lead drug candidate isn�t a nucleotide, that doesn�t mean it isn�t an attractive acquisition target.

�Certainly nucleotides are an exciting class but they�re not the only class we believe will be used in HCV treatment,� said Abrahams, adding that doctors will be looking to use the drugs in combination to get the best results.

�Achillion only needs to get a relatively small segment of the market for it to be meaningful to a company of its size,� he added. Wells Fargo has a price target of $14 to $16 a share on the stock.

Meanwhile, Bayko, who has a hold rating on Achillion, said she doesn�t see a takeout on the horizon.

�I don�t think in the next six months they�ll be a takeout of Achillion or Idenix,�she said.